Stock In Spotlight: BioAmber Inc. (NYSE:BIOA)


BioAmber Inc. (NYSE:BIOA) closed its last session at $0.07. The stock traded within a range of $0.063 and $0.090. The company operates in the Basic Materials sector with a market capitalization of 3580. Trading volume for BioAmber Inc. was 12.99 Million in its previous trading session. Currently, BioAmber Inc. (NYSE:BIOA) has an average volume of 1.83 Million.

Company Profile

BioAmber Inc. is a bio-based chemicals company. It produces and sells bio-succinic acid. The company’s technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstock into chemicals for use in products including plastics, resins, food additives and personal care products. It operates in France, China, Canada, and the United States. BioAmber Inc. is based in Plymouth, Minnesota.

Analyst Views

BioAmber Inc. (NYSE:BIOA) received a Buy rating from 0 analysts. 0 analysts gave its stock an Outperform rating. 0 analysts say it’s a Hold while 0 analysts provided their expert opinion as Sell.

BioAmber Inc. (NYSE:BIOA) touched its 1-Year High price of $3.740 on 02/09/18 and its 1-Year Low price of $0.070 on 02/14/18.

EPS & Financials

BioAmber Inc. (NYSE:BIOA) reported its EPS in the last quarter as $-0.2/Share lagging the analyst estimate of $-0.13/Share by a difference of $-0.07. This showed a surprise of -53.8% in the last quarter earnings.

For the current quarter, 0 analysts are projecting a mean EPS of $0/share. According to their observations and findings, the stock could provide a high EPS of $0/share and a low EPS of $0/share.

Analysts believe that the company has the potential to earn average revenue of $3.3 Million for the current quarter. According to their predictions high & low revenue estimates are 6.75 Million and 6.75 Million respectively.

Technical Analysis

By taking a look at the stock’s current statistics it can gauged that the stock candle is BEARISH with HIGH volatility. BioAmber Inc. (NYSE:BIOA) has a 20-Day average volume of 4.5 Million. According to today’s trading volume BioAmber Inc. is ABOVE its 20-Day Avg. volume with the stock showing ABOVE Abnormal volume in the past 150 days.

Moving average convergence divergence (MACD) shows that the stock is on a PRICE RELATIVITY trend. The trend for the past 10-days shows that the company was in BEARISH territory while an analysis of the last 40-Day trend shows a BEARISH signal. The 100-Day trend also shows a BEARISH trend as well.

The company currently has an insider ownership of 1.5 Percent and Institutional ownership of 35.6 Percent. The return on assets stands at -15.8%, Return on Equity currently is -33.5% and the Return on Investment value is -25.7%.

BioAmber Inc. (NYSE:BIOA) gross margin percentage stands at -76% while its operating margin for the past trailing twelve month is 0 percent and its overall profit margin (ttm) is 0 Percent. The stock is currently moving below its 20-Day Simple Moving Average of -80.19% with a 50-Day Simple Moving Average of -82.28 percent. As of today, the company has a SMA200 (200-day simple moving average) of -93.89 Percent. The Stock has YTD (year to date) performance of -83.38 percent.

The TTM operating margin for the company stands at 0%. The return on invested capital is at -25.7%, which is good, compared to its peers. The Free Cash Flow or FCF margin is 0.

The company’s stock is currently moving with a -ve distance from the 200 day SMA of approximately -93.89%, and has a solid year to date (YTD) performance of -83.38% which means that the stock is constantly adding to its value from the previous fiscal year end price.